Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02452320 · ClinicalTrials.gov registry record · Phase 4
Prospective, Double Blind, Placebo Control, Bariatric IV Ace
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 4
- Development phase
- 136
- Enrollment target
NCT02452320 is a Phase 4 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 136 participants.
The verdict
NCT02452320, a Phase 4 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 136 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the administration of acetaminophen given intravenously (through an IV) beginning during surgery and then for 3 additional doses during the first 24 hours post-operatively will reduce the length of time subjects undergoing elective sleeve gastrectomy spend in the hospital following this operation. Additional questions that may be answered include whether administration of the study medication leads to improvement in pain control, a reduction in post-operative nausea and vomiting, and an overall improvement in quality of recovery.
Interventions
- DRUG Placebo
- DRUG intravenous acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02452320
The ClinicalTrials.gov registry entry for NCT02452320 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02452320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02452320 about?
NCT02452320 is a clinical study titled "Prospective, Double Blind, Placebo Control, Bariatric IV Ace". The purpose of this study is to determine if the administration of acetaminophen given intravenously (through an IV) beginning during surgery and then for 3 additional doses during the first 24 hours post-operatively will reduce the length of time subjects undergoing elective sleeve gastrectomy spen...
What is the current status of trial NCT02452320?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 136 participants. The study started on 2016-02. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02452320?
The interventions under investigation include: Placebo (DRUG), intravenous acetaminophen (DRUG).
Who is sponsoring clinical trial NCT02452320?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.